ERBB2 and breast cancer: Quantitative RT-PCR analysis of 45 breast cancer tissues and their corresponding serum samples indicated the levels of miR-1 expression in the Her2+ tumors were significantly lower than that in the luminal A and B tumors, but significantly higher than that in the basal-like tumors (Figure 1B).